Literature DB >> 10943993

Optimized binding of [35S]GTPgammaS to Gq-like proteins stimulated with dopamine D1-like receptor agonists.

S Panchalingam1, A S Undie.   

Abstract

Subtypes of dopamine D1-like receptors are coupled through the G proteins Gs or Gq to stimulate either adenylate cyclase or phospholipase C signaling cascades. In the present study, we have uncovered the marked enhancement by sodium deoxycholate of D1-like agonist-stimulated [35S]GTPgammaS binding to Gq-like G proteins in brain membranes, and determined the optimal experimental conditions for assessing agonist effects on [35S]GTPgammaS binding in the presence of the detergent. Factors and their optimal levels that were found to significantly enhance the sensitivity and robustness of the agonist-stimulated [35S]GTPyS binding reaction include protein concentration at 40 microg/ml, cationic concentrations of 120 mM Na+, 1.8 mM K+, and 20 mM Mg(2+), a molar guanine nucleotide ratio of 100,000 GDP to [35S]GTPgammaS, the presence of 1 mM deoxycholate, and an overall incubation duration of 30-120 min. Under the optimized conditions, the D1-like agonist SKF38393 induced potent and highly efficacious (up to 1000%) stimulation of [35S]GTPgammaS binding in membrane preparations from the striatum and other rat brain regions. In striatal membranes incubated with drug for 2 h, immunoprecipitation of the [35S]GTPgammaS-bound proteins with specific Galpha antibodies showed that at least 70% of SKF38393-stimulated [35S]GTPgammaS binding was to Galphaq. The present reaction parameters are consistent with conditions previously found to support dopaminergic stimulation of phospholipase C-mediated signaling in brain slice preparations. These results imply that different but equally physiologically relevant conditions can be obtained under which subtypes of dopaminergic receptors may couple preferentially to Galphas and the adenylate cyclase pathway or to Galphaq and the phospholipase C pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10943993     DOI: 10.1023/a:1007553004615

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

Review 1.  The GTP binding motif: variations on a theme.

Authors:  M Kjeldgaard; J Nyborg; B F Clark
Journal:  FASEB J       Date:  1996-10       Impact factor: 5.191

2.  Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C beta by G protein alpha and beta gamma subunits.

Authors:  A V Smrcka; P C Sternweis
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

3.  Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding.

Authors:  A Lorenzen; M Fuss; H Vogt; U Schwabe
Journal:  Mol Pharmacol       Date:  1993-07       Impact factor: 4.436

4.  Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions.

Authors:  T Costa; J Lang; C Gless; A Herz
Journal:  Mol Pharmacol       Date:  1990-03       Impact factor: 4.436

5.  Activation of phospholipase C in rabbit brain membranes by carbachol in the presence of GTP gamma S; effects of biological detergents.

Authors:  H R Carter; M A Wallace; J N Fain
Journal:  Biochim Biophys Acta       Date:  1990-08-13

6.  Carbachol in the presence of guanosine 5'-O-(3-thiotriphosphate) stimulates the breakdown of exogenous phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol 4-phosphate, and phosphatidylinositol by rat brain membranes.

Authors:  E Claro; M A Wallace; H M Lee; J N Fain
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

7.  Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studies.

Authors:  D E Selley; J M Bidlack
Journal:  J Pharmacol Exp Ther       Date:  1992-10       Impact factor: 4.030

8.  Analysis of receptor-stimulated and basal guanine nucleotide binding to membrane G proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  E Friedman; P Butkerait; H Y Wang
Journal:  Anal Biochem       Date:  1993-10       Impact factor: 3.365

9.  Effects of magnesium ion on the interaction of atrial muscarinic acetylcholine receptors and GTP-binding regulatory proteins.

Authors:  K Shiozaki; T Haga
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

10.  Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices.

Authors:  A S Undie; E Friedman
Journal:  J Neurochem       Date:  1994-07       Impact factor: 5.372

View more
  6 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

Review 2.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

3.  A computational model of dopaminergic modulation of hippocampal Schaffer collateral-CA1 long-term plasticity.

Authors:  Joseph T Schmalz; Gautam Kumar
Journal:  J Comput Neurosci       Date:  2021-08-25       Impact factor: 1.621

Review 4.  Dopamine receptor signaling and current and future antipsychotic drugs.

Authors:  Kevin N Boyd; Richard B Mailman
Journal:  Handb Exp Pharmacol       Date:  2012

5.  Approaches to Assess Functional Selectivity in GPCRs: Evaluating G Protein Signaling in an Endogenous Environment.

Authors:  Laura M Bohn; Lei Zhou; Jo-Hao Ho
Journal:  Methods Mol Biol       Date:  2015

6.  Constitutively active BRS3 is a genuinely orphan GPCR in placental mammals.

Authors:  Huihao Tang; Chuanjun Shu; Haidi Chen; Xiaojing Zhang; Zhuqing Zang; Cheng Deng
Journal:  PLoS Biol       Date:  2019-03-06       Impact factor: 8.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.